- Release Date: 23/09/21 08:39
- Summary: FDA Extends New Drug Application Review Period for Illuccix
- Price Sensitive: Yes
- Download Document 212.47KB
- Forums
- ASX - By Stock
- TLX
- Ann: FDA Extends New Drug Application Review Period for Illuccix
Ann: FDA Extends New Drug Application Review Period for Illuccix
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$18.65 |
Change
-0.140(0.75%) |
Mkt cap ! $6.287B |
Open | High | Low | Value | Volume |
$18.66 | $18.85 | $18.53 | $5.582M | 299.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 243 | $18.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.66 | 2135 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 240 | 18.650 |
7 | 656 | 18.640 |
9 | 1186 | 18.630 |
8 | 856 | 18.620 |
7 | 1206 | 18.610 |
Price($) | Vol. | No. |
---|---|---|
18.660 | 47 | 1 |
18.670 | 1130 | 13 |
18.680 | 839 | 6 |
18.690 | 1295 | 11 |
18.700 | 1254 | 9 |
Last trade - 11.30am 29/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online